A novel phospholipid-based drug formulation inhibits the age- and LPS-related increase in microglial activation.
- Darren S.D. Martin (Speaker)
- M. Walsh (Speaker)
- A. Miller (Speaker)
- Nolan, Y. (Speaker)
- A Mandel (Speaker)
- Anthony E. Bolton (Speaker)
- Marina A. Lynch (Speaker)
Activity: Talk or presentation › Invited talk